The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
Open accessAbstract
3S(-)-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4- benzodiazepine-3-yl)-1H-indole-2-carboxamide (L-364,718) interacted in a competitive manner with rat pancreatic cholecystokinin (CCK) receptors as determined by Scatchard analysis of the specific binding of 125I-labeled CCK. The affinity of L-364,718 for both pancreatic (IC50, 81 pM) and gallbladder (IC50, 45 pM) CCK receptors in radioligand binding assays greatly exceeded that of other reported nonpeptide CCK antagonists and was similar to that of CCK itself. In vitro functional studies utilizing CCK-induced contractions of the isolated guinea pig ileum and colon further demonstrated that L-364,718 acts as a competitive CCK antagonist, which lacks agonist activity and has a similar high affinity in these tissues (pA2, 9.9). L-364,718 exhibited a very high selectivity for peripheral CCK receptors relative to brain CCK, gastrin, and various other peptide and nonpeptide receptors in both in vitro radioligand and isolated tissue assays. In vivo, low intravenous doses of L-364,718 (0.1 mg/kg) markedly antagonized the contractions of the guinea pig gallbladder produced by intravenous administration of CCK for at least 2 hr. Administered orally, L-364,718 (ED50, 0.04 mg/kg) was highly effective as an antagonist of CCK-induced inhibition of gastric emptying in mice. The biochemical and pharmacological properties of L-364,718--namely, very high affinity and selectivity for peripheral CCK receptors, long-lasting in vivo efficacy, and oral bioavailability--makes this compound a powerful tool for investigating the physiological and pharmacological actions of CCK, and possibly its role in gastrointestinal disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
Lee, J. H., Kim, S.-Y., Kwon, Y. K., Kim, B. J., & So, I. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350075 · Cited by 1,380
Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding
Braestrup, C., & Squires, R. F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3805 · Cited by 1,264
Muscarinic Cholinergic Binding in Rat Brain
Yamamura, H. I., & Snyder, S. H. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.5.1725 · Cited by 1,203
Leysen, J. E., Niemegeers, C. J., Van Nueten, J. M., & Laduron, P. M. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14623-3 · Cited by 1,071
The Combinations of Haemoglobin with Oxygen and with Carbon Monoxide. I
Hill, A. V. (1913) · Biochemical Journal · doi:10.1042/bj0070471 · Cited by 800
The origin of acetylcholine released from guinea‐pig intestine and longitudinal muscle strips
Paton, W. D. M., & Zar, M. A. (1968) · The Journal of Physiology · doi:10.1113/jphysiol.1968.sp008392 · Cited by 610
Distinct cholecystokinin receptors in brain and pancreas.
Innis, R. B., & Snyder, S. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6917 · Cited by 573
Beta Adrenergic Receptor Binding in Membrane Preparations from Mammalian Brain
BYLUND, D. B., & SNYDER, S. H. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10785-2 · Cited by 568
BENNETT, J. P., & SNYDER, S. H. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10753-0 · Cited by 508
BURT, D. R., CREESE, I., & SNYDER, S. H. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10800-6 · Cited by 475
Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors
Greengrass, P., & Bremmer, R. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90202-4 · Cited by 417
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
Evans, B. E., Bock, M. G., Rittle, K. E., DiPardo, R. M., Whitter, W. L., Veber, D. F., Anderson, P. S., & Freidinger, R. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4918 · Cited by 327
Chang, R., Lotti, V., Monaghan, R., Birnbaum, J., Stapley, E., Goetz, M., Albers-Schonberg, G., Patchett, A., Liesch, J., Hensens, O., et al. (1985) · Science · doi:10.1126/science.2994227 · Cited by 319
Self-citationWatson, M., Yamamura, H. I., & Roeske, W. R. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90652-5 · Cited by 291
Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
Hahne, W. F., Jensen, R. T., Lemp, G. F., & Gardner, J. D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6304 · Cited by 236
Le Fur, G., Guilloux, F., Rufat, P., Benavides, J., Uzan, A., Renault, C., Dubroeucq, M. C., & Guérémy, C. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90063-2 · Cited by 227
Chang, R. S. L., Tran, V. T., & Snyder, S. H. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb02276.x · Cited by 224
Self-citation[3H]rauwolscine (α-yohimbine): A specific antagonist radioligand for brain α2-adrenergic receptors
Perry, B. D., & U'Prichard, D. C. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90123-0 · Cited by 187
Opiate receptor binding affected differentially by opiates and opioid peptides
Childers, S. R., Creese, I., Snowman, A. M., & Snyder, S. H. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90142-0 · Cited by 186
Miller, L. J., Rosenzweig, S. A., & Jamieson, J. D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43289-9 · Cited by 93
Chang, R. S. L., Lotti, V. J., Martin, G. E., & Chen, T. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90224-2 · Cited by 88
Self-citation
Cited by
Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167
Biological actions of cholecystokinin
Crawley, J. N., & Corwin, R. L. (1994) · Peptides · doi:10.1016/0196-9781(94)90104-x · Cited by 712
Expression cloning and characterization of the canine parietal cell gastrin receptor.
Kopin, A. S., Lee, Y. M., McBride, E. W., Miller, L. J., Lu, M., Lin, H. Y., Kolakowski, L. F., & Beinborn, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3605 · Cited by 508
Hughes, J., Boden, P., Costall, B., Domeney, A., Kelly, E., Horwell, D. C., Hunter, J. C., Pinnock, R. D., & Woodruff, G. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6728 · Cited by 501
Cholecystokinin and Gastrin Receptors
Dufresne, M., Seva, C., & Fourmy, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00014.2005 · Cited by 476
Metadata
- Authors
- Chang, R. S., & Lotti, V. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-07
- Volume
- 83
- Issue
- 13
- Pages
- 4923-4926
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1965260950
- Cited by
- 540
- References
- 22
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.